Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Amylase 1b Inhibitors

Amylase 1b inhibitors are a specific class of chemical compounds that target the enzyme Amylase 1b, which is a variant of alpha-amylase involved in the breakdown of complex carbohydrates into simpler sugars. Amylase 1b, like other alpha-amylases, plays a crucial role in the digestion of starches, facilitating their conversion into sugars such as maltose and glucose. These sugars are then further metabolized by the body for energy production. Inhibitors of Amylase 1b are designed to interfere with this enzymatic process by binding to the active site or other critical regions of the enzyme, thereby preventing it from interacting with its starch substrate. This inhibition disrupts the catalytic activity of Amylase 1b, reducing its ability to break down starches and thus slowing the overall process of carbohydrate digestion.

The process of developing Amylase 1b inhibitors involves several steps, beginning with a thorough understanding of the enzyme's structure and function. Structural analysis techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, are employed to map the three-dimensional configuration of Amylase 1b. These structural insights are essential for identifying potential binding sites for inhibitors and understanding how the enzyme interacts with its substrates at a molecular level. Once potential binding sites are identified, researchers use computational modeling and high-throughput screening to identify or design chemical compounds that can effectively bind to these sites and inhibit the enzyme's activity. These compounds are then synthesized and tested in vitro to evaluate their binding affinity, specificity, and inhibitory potency against Amylase 1b. The results of these tests inform further refinement of the inhibitors, with the goal of enhancing their effectiveness and selectivity. Through this iterative process of design, testing, and optimization, researchers develop potent Amylase 1b inhibitors that provide valuable tools for studying the enzyme's role in carbohydrate metabolism and contribute to a deeper understanding of enzymatic regulation within biological systems.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Acarbose

56180-94-0sc-203492
sc-203492A
1 g
5 g
$226.00
$605.00
1
(1)

Acarbose acts as a competitive inhibitor by mimicking starch, potentially inhibiting Amylase 1b by binding to its active site.

Miglitol

72432-03-2sc-221943
10 mg
$161.00
1
(1)

Miglitol, a glucose analog, may act as a feedback inhibitor for Amylase 1b, binding to its active site and preventing activity.

Voglibose

83480-29-9sc-204384
sc-204384A
10 mg
50 mg
$198.00
$681.00
(1)

Voglibose could inhibit Amylase 1b by competitively binding to its active site, blocking substrate access.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$73.00
$145.00
(0)

Deoxynojirimycin could inhibit Amylase 1b by mimicking its carbohydrate substrates and binding to the enzyme.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$184.00
$632.00
10
(1)

Castanospermine, binding to the active site of glycosidase enzymes, might similarly inhibit Amylase 1b's activity.